Post-operative urinary tract infection. Infection and inflammatory reaction due to urinary catheter
Conditions
Interventions
Intervention 1: Intervention group: receiving single dose intravenous ciprofloxacin (400 mg) before procedure. Intervention 2: Control group:receiving single dose intravenous ciprofloxacin (400 mg) be
Sponsors
Urology Research Center, Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Have a sterile urine culture before stent placement
Exclusion criteria
Exclusion criteria: Fever Use of antibiotics during the 2 weeks before the stenting operation Purulent discharge during TUL History or treatment of obstructive symptoms Chronic bacterial prostatitis Chronic pelvic pain syndrome Prostate cancer Chronic ureteral obstruction Obstruction due to malignancy Iatrogenic trauma Conditions prone to bleeding History of bladder cancer Recurrent urinary tract infections Irritable bladder syndrome History of mental or neurological disease Taking alpha-blockers and anticholinergics, painkillers, or other medications that may interfere with the symptoms of ureteral stent Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary tract infection after inserting the stent. Timepoint: The mean duration of stent indwelling time and before removing the stent. Method of measurement: Urine culture and urinalysis.;Fever. Timepoint: During the stent indwelling time. Method of measurement: Interview and physical exam.;Hematuria. Timepoint: During of stent indwelling time and before removing the stent. Method of measurement: Interview and questionnaire.;Dysuria. Timepoint: During of stent indwelling time and before removing the stent. Method of measurement: Interview and questionnaire.;Frequency. Timepoint: During of stent indwelling time and before removing the stent. Method of measurement: Interview and questionnaire.;Nocturia. Timepoint: During of stent indwelling time and before removing the stent. Method of measurement: Interview and questionnaire.;Flank pain. Timepoint: During of stent indwelling time and before removing the stent. Method of measurement: Interview and questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of contentious antibiotics. Timepoint: During of stent indwelling time. Method of measurement: Interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahador Heidari Bateni
Rasht University of Medical Sciences
Outcome results
None listed